logo
Sign in

NORD Stock Price, Chart, Stats & News

Nordicus Partners Corporation
Save

Nordicus Partners Corporation (NORD) does not currently pay a dividend.

58.14M
Market cap
–
Current P/E
–
Forward P/E

NORD chart

About

Health care
Sector
Biotechnology
Industry

Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services.

Similar securities

Based on sector and market capitalization

Report issue